Regulatory Affairs: The IND, NDA, and Post-Marketing

Attend this virtual training course to learn about FDA regulations and expectations for the content, submission and review of INDs/NDAs, and the importance of regulatory strategy.

戻る Agenda

Regulatory Affairs: Part 7: Mock FDA Meeting

Session Chair(s)

Elliott Berger, PhD, MS

President

ETB Regualtory Consulting, United States

Regulatory Affairs: Part 7: Mock FDA Meeting

Regulatory Affairs: The IND, NDA, and Post-Marketing

Regulatory Affairs: Part 7: Mock FDA Meeting

Session Chair(s)

Elliott Berger, PhD, MS

最新情報や機会を逃さないで